Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance O Lautner-Csorba, A Gézsi, ÁF Semsei, P Antal, DJ Erdélyi, G Schermann, ... BMC medical genomics 5, 1-15, 2012 | 63 | 2012 |
Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis O Lautner-Csorba, A Gezsi, DJ Erdelyi, G Hullam, P Antal, AF Semsei, ... PloS one 8 (8), e69843, 2013 | 55 | 2013 |
Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma M Hegyi, A Arany, AF Semsei, K Csordas, O Eipel, A Gezsi, N Kutszegi, ... Oncotarget 8 (6), 9388, 2017 | 46 | 2017 |
Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma JC Sági, B Egyed, A Kelemen, N Kutszegi, M Hegyi, A Gézsi, ... BMC cancer 18, 1-14, 2018 | 42 | 2018 |
HLA-DRB1* 07: 01–HLA-DQA1* 02: 01–HLA-DQB1* 02: 02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia N Kutszegi, X Yang, A Gézsi, G Schermann, DJ Erdélyi, ÁF Semsei, ... haematologica 102 (9), 1578, 2017 | 37 | 2017 |
Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia A Rzepiel, N Kutszegi, A Gézsi, JC Sági, B Egyed, G Péter, H Butz, ... Journal of translational medicine 17, 1-16, 2019 | 30 | 2019 |
MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia B Egyed, N Kutszegi, JC Sági, A Gézsi, A Rzepiel, T Visnovitz, P Lőrincz, ... Journal of Translational Medicine 18, 1-12, 2020 | 22 | 2020 |
Pharmacogenetics of anthracyclines JC Sági, N Kutszegi, A Kelemen, LE Fodor, A Gézsi, GT Kovács, ... Pharmacogenomics 17 (9), 1075-1087, 2016 | 21 | 2016 |
Subgroups of paediatric acute lymphoblastic leukaemia might differ significantly in genetic predisposition to asparaginase hypersensitivity N Kutszegi, ÁF Semsei, A Gézsi, JC Sági, V Nagy, K Csordas, Z Jakab, ... PloS one 10 (10), e0140136, 2015 | 19 | 2015 |
In interaction with gender a common CYP3A4 polymorphism may influence the survival rate of chemotherapy for childhood acute lymphoblastic leukemia A Gézsi, O Lautner-Csorba, DJ Erdélyi, G Hullám, P Antal, ÁF Semsei, ... The pharmacogenomics journal 15 (3), 241-247, 2015 | 16 | 2015 |
New and traditional directions in the biology and management of childhood acute lymphoblastic leukemia B Egyed, G Kovács, N Kutszegi, A Rzepiel, DJ Erdélyi, J Müller Orvosi Hetilap 159 (20), 786-797, 2018 | 5* | 2018 |
MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemia A Rzepiel, A Horváth, N Kutszegi, A Gézsi, JC Sági, L Almási, B Egyed, ... Molecular and Cellular Probes 67, 101893, 2023 | 4 | 2023 |
Two tagging single‐nucleotide polymorphisms to capture HLA‐DRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype associated with asparaginase hypersensitivity N Kutszegi, A Gézsi, Á F. Semsei, J Müller, R Simon, ER Kovács, ... British Journal of Clinical Pharmacology 87 (6), 2542-2548, 2021 | 3 | 2021 |
Monitoring the potential role of circulating miR-181b-5p in minimal residual disease in paediatric acute lymphoblastic leukaemia N Kutszegi, A Rzepiel, A Gézsi, M Papp, B Egyed, H Butz, JC Csányi, ... Journal of Extracellular Vesicles 7, 241-241, 2018 | 2 | 2018 |
Extracellular vesicles and their role in hematological malignancies A Rzepiel, N Kutszegi, C Sági, A Kelemen, K Pálóczi, E Buzás, DJ Erdélyi Orvosi Hetilap 157 (35), 1379-1384, 2016 | 2* | 2016 |
GENETIC RISK FACTORS OF ANTHRACYCLINE CARDIOTOXICITY-RELEVANT POLYMORPHISMS IDENTIFIED IN ENZYMES AND TRANSPORTERS OF ANTHRACYCLINE PHARMACOKINETICS NZ Kutszegi, AF Semsei, O Lautner-Csorba, M Hegyi, J Szabolcs, ... Pediatric Blood & Cancer 59 (6), 1101-1101, 2012 | 1 | 2012 |
980 genetic risk factors of neurotoxicity during chemotherapy A Semsei, O Lautner-Csorba, G Schermann, N Kutszegi, A Falus, ... european journal of cancer, S236, 2012 | 1 | 2012 |
Novel Liquid Biopsy Markers of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia B Egyed, N Kutszegi, JC Sagi, A Gezsi, A Rzepiel, T Visnovitz, C Szalai, ... PEDIATRIC BLOOD & CANCER 68, S175-S176, 2021 | | 2021 |
ALL-198: Pharmacogenetic Study on Central Nervous System Relapse Among Patients with Pediatric Acute Lymphoblastic Leukemia in Hungary JC Sagi, A Artner, B Egyed, A Rzepiel, N Kutszegi, A Gezsi, L Tiszlavicz, ... Clinical Lymphoma Myeloma and Leukemia 20, S164, 2020 | | 2020 |
New Liquid Biopsy Markers for the Detection of Central Nervous System Involvement in Childhood Acute Leukemia B Egyed, JC Sági, N Kutszegi, A Gézsi, A Rzepiel, C Szalai, GT Kovács, ... Clinical Lymphoma, Myeloma and Leukemia 19, S187-S188, 2019 | | 2019 |